Back to search

Article

Efficacy of crisugabalin (HSK16149) for refractory chronic cough: study protocol for a randomized, double-blind, placebo-controlled trial

2026-08-12

Abstract excerpt

<title>Abstract</title> <p>Background: Refractory chronic cough (RCC) persists despite systematic evaluation showing no clear cause, or despite adequate treatment of an identified or strongly suspected cause. RCC remains difficult to treat. Although gabapentinoids can reduce cough and improve quality of life, their benefits may be limited by slow onset, central nervous system adverse effects, and relapse after di...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
98717ede-379f-5fa3-a393-7b3af00070fb
DOI
10.21203/rs.3.rs-8997408/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficacy of crisugabalin (HSK16149) for refractory chronic cough: study protocol for a randomized, double-blind, placebo-controlled trialDOI 10.21203/rs.3.rs-8997408/v1
Select a neighboring publication to make it the new centre.